NIZHNY NOVGOROD (Sputnik) – Clinical trials of a COVID-19 vaccine, developed by the Gamaleya Institute of Epidemiology and Microbiology, have been completed, Russian Minister of Health Mikhail Murashko said.
“The vaccine against coronavirus infection, developed by the Gamaleya Institute, has completed clinical trials,” Murashko told reporters, answering a question about whether the clinical trials of the vaccine are officially completed.
Murashko also said that the health ministry expects at least two requests to begin clinical trials in the coming two months.
He noted that the packet of documents for vaccine registration is being prepared.
Sourse: sputniknews.com
